Eilean Therapeutics is a biotechnology company developing first- and best-in-class small molecule therapies for hematologic malignancies and genetically defined cancers. Leveraging an AI-enabled drug discovery platform, advanced medicinal chemistry, and translational biology, Eilean designs precision therapies targeting resistance mechanisms and validated cancer drivers to deliver transformative treatments for patients with high unmet medical needs.